Former CEO-Physician and Drug Testing Laboratory Pay $9.35 Million to Settle False Claims Act Allegations
Dr. Jonathan Oppenheimer, former owner and CEO of Nashville drug testing laboratory Prost-Data, Inc., d/b/a OURLab ("OURLab"), OPKO Health, Inc. ("OPKO"), and OPKO Lab, LLC, have agreed to pay $9.35 million to resolve False Claims Act ("FCA") allegations, announced David Rivera, United States Attorney for the Middle District of Tennessee. Pursuant to the civil settlement, Oppenheimer, and OPKO will be jointly and severally liable for the settlement amount. OPKO is a successor to OPKO Lab, LLC, which purchased OURLab from Oppenheimer in December 2012, after OURLab and Oppenheimer instituted the alleged conduct. OPKO Lab, LLC ceased commercial operations in early 2016 and is no longer billing federal payors. Oppenheimer has agreed to an exclusion from participation in all federal health care programs for 5 years as part of the agreement.
- Date:June 1, 2016
- Agency:U.S. Attorney
- Criminal and Civil Actions